Hyphens Pharma Expands Cerapro® MED Skin Barrier Cream to Six European Markets Hyphens Pharma announces the licensing of Cerapro® MED Skin Barrier Cream to Louis Widmer SA for distribution in six European countries. This innovative product offers new hope for those suffering from atopic dermatitis.

Hyphens Pharma Expands Cerapro® MED Skin Barrier Cream to Six European Markets #None #Hyphens_Pharma #Cerapro #Dermatitis

Hyphens Pharma Licenses Cerapro MED Skin Cream for Six European Markets Hyphens Pharma has entered a licensing agreement with Louis Widmer to market its Cerapro MED Skin Barrier Cream across six European countries, targeting atopic dermatitis.

Hyphens Pharma Licenses Cerapro MED Skin Cream for Six European Markets #Singapore #Louis_Widmer #Hyphens_Pharma #Cerapro